Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies